FHCRX Performance — Select Health Care Portfolio
Data updated: 2026-07-24
FHCRX returned −1.89% year to date and +19.50% over one year to May 2026. Annualised returns are +6.82% over 3 years and +2.50% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $122, against $131 for the category, and to $119 over one year, against $129. Volatility over the past three years was 14.33% a year. In the 12 months to May 2026 the fund lost a net $51.6M, and assets reached $5.78B. Returns are those of sibling share class FSPHX; this class's own returns are not reported in filings.
FHCRX Growth of $100
What $100 invested in Select Health Care Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | FHCRX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $119 | $129 |
| 3 years (Jun 2023 – May 2026) | $122 | $131 |
| 5 years (Jun 2021 – May 2026) | $113 | $116 |
| Since data start (Sep 2019 – May 2026) | $175 | $173 |
FHCRX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −1.89% |
| 1 year | +19.50% |
| 3 years (annualised) | +6.82% |
| 5 years (annualised) | +2.50% |
FHCRX Annual Returns
Calendar-year total returns of Select Health Care Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −1.89% |
| 2025 | +14.40% |
| 2024 | +4.94% |
| 2023 | +4.15% |
| 2022 | −12.84% |
| 2021 | +11.51% |
| 2020 | +24.44% |
| 2019 (Sep–Dec) | +18.11% |
FHCRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.1% | −0.2% | −6.0% | +1.3% | +3.2% | — | — | — | — | — | — | — |
| 2025 | +5.9% | −3.2% | −3.4% | −1.2% | −4.0% | +2.7% | −0.9% | +4.4% | +3.1% | +5.7% | +8.3% | −3.0% |
| 2024 | +0.6% | +4.8% | +1.2% | −4.8% | 0.0% | +2.5% | +2.6% | +6.3% | +0.4% | −3.7% | +3.2% | −7.4% |
| 2023 | +2.6% | −4.1% | +2.2% | +3.2% | −3.1% | +2.6% | +0.4% | −2.8% | −4.5% | −5.2% | +4.9% | +8.8% |
| 2022 | −13.4% | +1.1% | +4.2% | −9.7% | −2.1% | −0.7% | +8.2% | −3.0% | −2.5% | +5.0% | +3.8% | −2.5% |
| 2021 | +1.9% | −0.7% | +0.4% | +5.3% | −1.6% | +3.1% | +0.8% | +2.7% | −4.7% | +5.3% | −7.0% | +6.1% |
| 2020 | −1.2% | −6.1% | −4.1% | +13.9% | +5.5% | +1.6% | +2.4% | +2.1% | +0.3% | −1.7% | +7.4% | +3.6% |
| 2019 | — | — | — | — | — | — | — | — | −3.3% | +6.7% | +9.0% | +5.0% |
FHCRX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 14.33%
- 3-year Sharpe ratio: 0.16 (vs 4.5% risk-free rate)
- Best month: +8.82% (Dec 2023)
- Worst month: −7.45% (Dec 2024)
FHCRX Fund Flows
Monthly money in and out of Select Health Care Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$51.6M
- 12-month gross sales (incl. reinvestments): $1.3B
- Sales ÷ redemptions: 0.96×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $33.4M | $112.1M | −$78.7M |
| Apr 2026 | $628.7M | $137.8M | $490.9M |
| Mar 2026 | $22.6M | $72.1M | −$49.6M |
| Feb 2026 | $19.6M | $84.4M | −$64.7M |
| Jan 2026 | $31.6M | $119.4M | −$87.8M |
| Dec 2025 | $430.7M | $109.4M | $321.3M |
| Nov 2025 | $35.5M | $93.3M | −$57.8M |
| Oct 2025 | $24.5M | $111.7M | −$87.2M |
| Sep 2025 | $17.1M | $116.5M | −$99.4M |
| Aug 2025 | $19.9M | $125.2M | −$105.4M |
| Jul 2025 | $15.7M | $152.4M | −$136.7M |
| Jun 2025 | $13.5M | $110.0M | −$96.5M |
FHCRX Assets Under Management
Net assets of Select Health Care Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $5.78B |
| 2026-02-28 | $6.20B |
| 2025-11-30 | $6.67B |
| 2025-08-31 | $5.88B |
| 2025-05-31 | $5.86B |
| 2025-02-28 | $6.74B |
| 2024-11-30 | $7.51B |
| 2024-08-31 | $7.81B |
| 2024-05-31 | $7.30B |
| 2024-02-29 | $7.92B |
| 2023-11-30 | $7.35B |
| 2023-08-31 | $8.06B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.